Speak with an expert about your biomarker discovery needs。
接触规范
![测试tubes](/webroot/web/images/lsr/solutions/applications/protein_functional_analysis/biomarker_analysis/biomarker-apptech-parent-main.png)
We have solutions that address key challenges in biomarker discovery and validation:throughput,reliability,sensitivity,and ease of use。开挖口解决方案,施工,开挖口,开挖口,开挖口,开挖口。
Biomarker Discovery解决方案
Biomarker Discovery
Biomarkers provide vital information regarding safety and efficacy during drug discovery and development.Biomarkers can be classified as diagnostic,prognostic,or predictive and can be used to select patients for clinical trials or monitor patient response and treatment efficy.In addition,after regulatory,apval, biomarkers can be used to identify patient populations that would benefit from a particular therapy,and biomarkers can be used in clinical diagnostics to confirm the efficacy of a treatment and monitor long-term safety。
Biomarkers are used in research to design and develop more effective therapeutics,to assist in guiding decisions about which candidates to develop further,as surrogate markers for the selection of patients,and as endpoints for both benefits and risks.There are awide range of types of biomarkers,as endpoints for for for direct,diture as, prognostic,pharmacodynamic,safety,and efficacy markers.One class of biomarkers that is actively being researched is safety biomarkers.These markers are being developed to help determine which drug candidates are most likely to be safely tolerated in humans。
从发现到验证
Biomarkers range from specific molecules such as a protein,gene sequence,or expressed RNA to physiological parameters such as blood pressure or body temperature.They may be expressed in a specific location or tissue or found in serum,plasma,and other bodily fluids.Because of this diversity, most successful biomarker programs have a broad reach and investigate cellular,proteomic,and genetic sources inorder to find the most valuable biomarkers。
Validation of biomarkers requires that their levels change in response to a disease,condition,or other parameter in a consistent and statistically significant manner.Identification and characterization of biomarkers can reduce the number of candidate drugs that fail clinical trials,aid in the discovery of mothere,aputive, and provide methods for monitoring animals in preclinical research and evaluating the response of human participants in clinical trials。